Combination Treatment of Post-Herpetic Neuralgia

Öz

Herpes zoster is a viral disease presenting with vesicular eruptions that are usually preceded by pain and erythema. Herpes zoster can be seen in any dermatome of the body but most commonly appears in the thoracic region. 88 years old, 70 kg female patient who came to our outpatient clinic with pain in the back and side pain. Very severe pain that can not sleep at night because of pain constantly moaning and relatives said. A multidisciplinary approach is required for the treatment of PHN From the family doctor, pain specialist, psychiatrist and neurologist required. Our patient was to evaluate the neurology and pain medicine.Proper medication and nerve block is defined as a combination therapy has been useful in our case.

 

Anahtar Kelimeler

• Herpes zoster ,postherpetic neuralgia ,nerve block

Postherpetik Nevraljinin KombinasyonTedavisi

Öz

Herpes zoster viral bir hastalık olup, genellikle ağrılı ve eritemli- veziküler döküntü halinde görülür. Herpes zoster vücudun herhangi bir dermatomunda görülebilir ama genellikle thorakal bölgelerdedir. 88 yaşında 70 kg ağırlığındaki bayan hasta sırtında ve yanlarında ağrıyla polikliniğimize geldi. Akrabalarının söylediğine göre geceleri çok şiddetli ağrı nedeniyle uyuyamamış ve sürekli inlemiş. Tedavide multidisipliner yaklaşım  uygulanabilmektedir. Bunun için aile doktoru, ağrı uzmanı, psikiyatrist ve nörolojist gereklidir. Hastamız uygun ilaç tedavisi ve sinir bloğu kombinasyonu ile tedavi edilmiştir.

 

 

Anahtar Kelimeler

• Herpes zoster, postherpetik nevralji, sinir bloğu

Kaynakça

1. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274–280. doi: 10.4065/84.3.274.
2. Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med. 2011;123(5):134–142. doi: 10.3810/pgm.2011.09.2469
3. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–1349. doi: 10.4065/82.11.1341
4. Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9(3 Suppl):21–26. doi: 10.1586/erv.10.30. McElveen WA. Postherpetic neuralgia differential diagnoses. http://emedicine.medscape.com/article/1143066-overview. Accessed 11 May 2011
5. Baron R, Tolle TR, Gockel U, et al. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain. 2009;146(1–2):34–40. doi: 10.1016/j.pain.2009.06.001.
6. Johnson RW. Herpes zoster and postherpetic neuralgia. Optimal treatment. Drugs&Aging 1997;10(2):80-94.
7. Kanazi GE, Johnson RW, Dworkin RH: Treatment of postherpetic neuralgia. An update. Drugs 2000;59(5):1113-1126.
8. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus Miller L: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280(21):1837-1842.

9. Wood MJ, Easterbrook PJ: Herpes zoster. Science press. London. 1995: 1-43.
10. Odom RB, James WD, Berger TG: Andrews’ diseases of the skin. 9th ed. Philadelphia, W.B. Saunders Company, 2000;489-490.
11. Tamakawa S, Ogawa H: Lidocaine tape (Penles-a dressing tape based on % 60 Lidocaine) reduces the pain of postherpetic neuralgia. Masui 1998; 47(7):882-884.